Academic collaboration and organizational innovation: The development of research capabilities in the US pharmaceutical industry, 1927-1946

Industrial and Corporate Change

Volumn 18, Issue 5, 2009, Pages 929-961

  Furman, Jeffrey L ^a   MacGarvie, Megan ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIRM SIZE; HISTORICAL GEOGRAPHY; INDUSTRIAL DEVELOPMENT; INNOVATION; LABOR MARKET; NINETEENTH CENTURY; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; UNIVERSITY SECTOR;

NORTH AMERICA; UNITED STATES;

EID: 70349612281     PISSN: 09606491     EISSN: 14643650     Source Type: Journal    
DOI: 10.1093/icc/dtp035     Document Type: Article

References (73)

1. Achilladelis, B. (1999), 'Innovation in the pharmaceutical industry,' in R. Landau, B. Achilladelis and A. Scriabine (eds), Pharmaceutical Innovation: Revolutionizing Human Health. Chemical Heritage Foundation Press: Philadelphia, PA, pp. 1-137.
2. Adams, J. D., E. P. Chiang and J. L. Jensen (2003), 'The influence of federal laboratory R&D on industrial research,' The Review of Economics and Statistics, 85(4), 1003-1020.
3. American Chemical Society (1924, 1930, 1947), Directory of members - American Chemical Society. American Chemical Society: Washington, DC.
4. American Council on Education, American Universities and Colleges, Washington: American Council on Education. 1936-40 and 1952.
5. Arora, A., R. Landau and N. Rosenberg (1998), Chemicals and Long-Term Economic Growth: Insights from the Chemical Industry. Wiley: New York.
6. Argyres, N. S. and J. P. Liebeskind (1998), 'Privatizing the intellectual commons: Universities and the commercialization of biotechnology,' Journal of Economic Behavior & Organization, 35 427-454.
7. Audretsch, D. B. and P. E. Stephan (1996), 'Company-scientist locational links: The case of biotechnology,' American Economic Review, 86 3), 641-652.
8. Ballentine, C. (1981), 'Taste of raspberries, taste of death: The 1937 Elixir Sulfanilamide incident,' FDA Consumer, 15, 18-21.
9. Bliss, M. (1984), The Discovery of Insulin. University of Chicago Press: Chicago, IL.
10. Cohen, W. M., R. Florida, L. Randazzese and J. Walsh (1998), 'Industry and the academy: Uneasy partners in the cause of technological advance,' in R. Noll (ed.), Challenges to Research Universities. The Brookings Institution: Washington, DC, pp. 171-199.
11. Feldman, M. P. (2003), 'The locational dynamics of the US biotech industry: Knowledge externalities and the anchor hypothesis,' Industry and Innovation, 10, 311-328.
12. Feldman, M. and Y. Schreuder (1996), 'Initial advantage: The origins of geographic concentration of the pharmaceutical industry in the Mid-Atlantic region,' Industrial and Corporate Change, 5, 839-862.
13. Fisk, C. (1998), 'Removing the 'Fuel of Interest' from the 'Fire of Genius': Law and the employee-nventor, 1830-1930,' University of Chicago Law Review, 65, 1127.
14. Furman, J. (2003), 'Location and organizing strategy? Exploring the influence of location on organization of pharmaceutical research,' in J. A. C. Baum and O. Sorenson (eds), Advances in Strategic Management Elsevier Science: Oxford UK, pp. 49-88.
15. Furman, J. L. and M. MacGarvie (2007), 'Academic science and the birth of industrial research laboratories in the US pharmaceutical industry,' Journal of Economic Behavior & Organization, 63(4), 756-776.
16. Galambos, L. and J. E. Sewell (1995), Networks of Innovation: Vaccine Development at Merck, Sharp & Dohme, and Mulford, 1985-1995. Cambridge University Press: Cambridge, UK.
17. Geiger, R. L. (1986), To Advance Knowledge: The Growth of American Research Universities, 1900-1940. Oxford University Press: New York, NY.
18. Goldin, C. and L. F. Katz (1999), 'The shaping of higher education: The formative years in the United States, 1890 to 1940,' Journal of Economic Perspectives, Winter, 37-62.
19. Graham, H. D. and N. Diamond (1997), The Rise of American Research Universities: Elites and Challengers in the Postwar Era. Johns Hopkins: Baltimore, MD.
20. Haynes, W. (1928), Who's Who in Chemistry. Haynes & George Co: New Haven, CT.
21. Heller, M. A. and R. S. Eisenberg (1998), 'Can patents deter innovation? The anticommons in biomedical research,' Science, 280 (5364), 698-701.
22. Hounshell, D. A. and J. K. Smith, Jr. (1988), Science and Corporate Strategy: DuPont R&D, 1902-1980. Cambridge University Press: New York, NY.
23. Israel, P. (2004), 'Waksman - Biography,' http://www.scc.rutgers.edu/njh/ SciANDTech/Waksman/biog.htm (accessed July 16, 2004).
24. Jaffe, A. B. and J. Lerner (2001), 'Reinventing public R&D: Patent policy and the commercialization of National Laboratory Technologies,' Rand Journal of Economics, 32, 167-198.
25. Jaffe, A., M. Trajtenberg and R. Henderson (1993), 'Geographic localization of knowledge spillovers as evidenced by patent citations,' Quarterly Journal of Economics, 108(3), 577-598.
26. Lamoreaux, N. and K. Sokoloff (1996), 'Long-term change in the organization of inventive activity,' Proceedings of the National Academy of Sciences, 93, 12686-12692.
27. Lamoreaux, N. and K. Sokoloff (2005), 'The Decline of the Independent Inventor: A Schumpeterian Story?' NBER Working Paper #11654.
28. Lewis, S. (1925), Arrowsmith. Grosset and Dunlap: New York, NY.
29. Lewin, A. Y. and H. W. Volberda (1999), 'Prolegomena on coevolution: A framework for research on strategy and new organizational forms,' Organization Science, 10(5), 519-534.
30. Lewin, A. Y., C. P. Long and T. N. Carroll (1999), 'The coevolution of new organizational forms,' Organization Science, 10(5), 535-550.
31. Liebenau, J. (1984), 'Industrial R&D in pharmaceutical firms in the early twentieth century,' Business History, 26, 330-346.
32. Liebenau, J. (1985), 'Innovation in pharmaceuticals: Industrial R&D in the early twentieth century,' Research Policy, 14, 179-187.
33. Liebenau, J. (1987), Medical Science and Medical Industry: The Formation of the American Pharmaceutical Industry. Johns Hopkins University Press: Baltimore, MD.
34. Liebenau, J. (1990), Pill Peddlers: Essays on the History of the Pharmaceutical Industry. American Institute of the History of Pharmacy: Madison, WI.
35. Mahoney, T. (1959), The Merchants of Life. Harper Brothers: New York, NY. Mann, C. C. and M. L. Plummer (1991), The Aspirin Wars. Knopf: New York, NY.
36. Mansfield, E (1991), 'Academic research and industrial innovation,' Research Policy, 20, 1-12.
37. Mansfield, E. (1995), 'Academic research underlying industrial innovations: Sources, characteristics, and financing,' Review of Economics and Statistics, 77, 55-65.
38. Moody's Manual of Industrial Securities (1939) and (1947), Moody's Investors Service: New York, NY.
39. Mowery, D. (1990), 'The development of industrial research in US manufacturing,' American Economic Review, 80(2), 345-349.
40. Mowery, D. C. and R. R. Nelson (eds) (1999), 'Explaining industrial leadership,' in Sources of Industrial Leadership: Studies of Seven Industries. Cambridge University Press: Cambridge, UK, pp. 359-382.
41. Mowery, D., R. Nelson, B. Sampat and A. Ziedonis (2003), '"Ivory Tower" and Industrial Innovation: University-Industry Technology Transfer Before and After the Bayh-Dole Act in the United States,' Unpublished manuscript.
42. Mowery, D. and N. Rosenberg (1998), Paths of Innovation: Technological Change in 20th-Century America. Cambridge University Press: Cambridge; New York.
43. Mowery, D. and B. Sampat (2004), 'The Bayh-Dole Act of 1980 and university-industry technology transfer: A model for other OECD governments?,' Journal of Technology Transfer, 30(1-2), 115-127.
44. Munroe, J. (2004), 'The University of Delaware: A History,' http://www.udel.edu/PR/munroe/ (accessed, July 1-7, 2004).
45. Murmann, J. P. (2003a), Knowledge and Competitive Advantage: The Coevolution of Firms, Technology, and National Institutions. Cambridge University Press: New York, NY.
46. Murmann, J. P. (2003b), 'The coevolution of industries and academic disciplines,' Evolutionary Theories in the Social Sciences, WP03-01.
47. Murmann, J. P. and R. Landau (1998), 'On the making of competitive advantage: The development of the chemical industries in Britain and Germany since 1850,' in A. Arora, R. Landau and N. Rosenberg (eds), Chemicals and Long-Term Economic Growth: Insights from the Chemical Industry. John Wiley & Sons: New York, pp. 27-70.
48. Murray, F. E and S. Stern (2006), 'Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis,' Journal of Economic Behavior & Organization, 63(4), 648-687.
49. Noble, D. F. (1977), America by Design: Science, Technology, and the Rise of Corporate Capitalism. Oxford University Press: Oxford, UK.
50. National Research Council (1921), Bulletin 16, 'Research Laboratories in Industrial Establishments of the United States, Including Consulting Research Laboratories.' National Research Council: Washington, DC.
51. National Research Council (1927-85), Industrial Research Laboratories of the United States. National Research Council: Washington, DC.
52. Nelson, R. and N. Rosenberg (1994), 'American universities and technical advance in industry,' Research Policy, 23, 323-348.
53. Nelson, R. R. and G. Wright (1992), 'The rise and fall of American technological leadership,' Journal of Economic Literature, 30 4), 1931-1964.
54. North, D. C. (1990), Institutions, Institutional Change, and Economic Performance. Cambridge University Press: Cambridge, UK.
55. Parascandola, J. (1985), 'Industrial research comes of age: The American pharmaceutical industry, 1920-1940,' Pharmacy in History, 27 1), 12-21.
56. Parascandola, J. (2000), 'The pharmaceutical sciences in America, 1852-1902,' Journal of the American Pharmaceutical Association, 40(2000), 733-735.
57. Parascandola, J. (2002), 'From germs to genes: Trends in drug therapy, 1852-2002,' Pharmacy in History, 44(1), 3-11.
58. Poyago-Theotoky, J., J. Beath and D. S. Siegel (2002), 'Universities and fundamental research: Reflections on the growth of university-industry partnerships,' Oxford Review of Economic Policy, 18(1), 10-21.
59. Rasmussen, N. (2002), 'Of 'small men,' big science and bigger business: the second world war and biomedical research in the United States,' Minerva, 40, 115-146.
60. Rasmussen, N. (2005), 'The drug industry and clinical research in interwar America: Three types of physician collaborator,' Bulletin of the History of Medicine, 79(1), 50-80.
61. Rosenberg, N. (2000), 'America's University/Industry Interfaces, 1945-2000,' Unpublished manuscript.
62. Rosenberg, N. and R. Nelson (1994), 'American universities and technical advance in industry,' Research Policy, 23, 323-348.
63. Siegel, D. S., M. Wright and A. Lockett (2007), 'The rise of entrepreneurial activity at universities: Organizational and societal implications,' Industrial and Corporate Change, 16(4), 489-504.
64. Siegel, D. S. (2003), 'Data requirements for assessing the impact of strategic research partnerships on economic performance: Analysis and recommendations,' Technology Analysis and Strategic Management, 15(2), 207-225.
65. Swann, J. P. (1988), Academic Scientists and the Pharmaceutical Industry. Johns Hopkins University Press: Baltimore.
66. Swann, J. P. (1990), 'Universities, industry, and the rise of biomedical collaboration in America,' in J. Liebenau, G. J. Higby and E. C. Stroud (eds), Pill Peddlers: Essays on the History of the Pharmaceutical Industry. American Institute of the History of Pharmacy: Madison, WI, pp. 73-90.
67. Temin, P et al. (eds), Pill Peddlers: Essays on the History of the Pharmaceutical Industry. American Institute of the History of Pharmacy: Madison, WI, pp. 73-90.
68. Temin, P (1979), '"Technology, regulation, and market structure in the modern pharmaceutical industry,' Bell Journal of Economics, 10 2), 429-446.
69. Thursby, J. and M. Thursby (2002), 'Who is selling the ivory tower? Sources of growth in university licensing,' Management Science, 48(1), 90-104.
70. Young, J. H. (1960), 'Patent medicines: An early example of competitive marketing,' The Journal of Economic History, 20(4), 648-656.
71. Young, J. H. (1961), The Toadstool Millionaires: A Social History of Patent Medicines in America before Federal Regulation. Princeton University Press: Princeton, NJ.
72. Wax, P. M. (1995), 'Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act,' Annals of Internal Medicine, 122(6), 456-461.
73. Zucker, L., M. Brewer and M. Darby (1998), 'Intellectual capital and the birth of US biotechnology enterprises,' American Economic Review, 88(1), 290-306.